PCP
AGIO icon

Proficio Capital Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Proficio Capital Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-73
Closed -$4K – 164
2019
Q2 		$4K Buy
73
+67
+1,117% +$3.58K ﹤0.01% 1258
2019
Q1 		$0 Buy
+6
New +$349 ﹤0.01% 1679
2018
Q4 		– Sell
-5
Closed – – 1173
2018
Q3 		$0 Hold
5
– – ﹤0.01% 1244
2018
Q2 		$0 Hold
5
– – ﹤0.01% 1277
2018
Q1 		$0 Buy
+5
New +$386 ﹤0.01% 1275
2016
Q3 		– Sell
-8
Closed – – 1081
2016
Q2 		$0 Buy
+8
New +$395 ﹤0.01% 1003

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Proficio Capital Partners's AGIO Position: Q3 2019 in Review

Proficio Capital Partners sold out of Agios Pharmaceuticals (AGIO) in Q3 2019, closing a stake of 73 shares — an estimated $4K sold.

Proficio Capital Partners first reported a position in AGIO in Q2 2016 and held it in 6 quarters. The position peaked at $4K in Q2 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

  • Proficio Capital Partners reported no remaining Agios Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 73 Agios Pharmaceuticals shares in Q3 2019, an estimated $4K.
  • Proficio Capital Partners first reported a position in Agios Pharmaceuticals in Q2 2016 and held it in 6 quarters.
  • Proficio Capital Partners's Agios Pharmaceuticals position peaked at $4K in Q2 2019.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.